Please login to the form below
Akili Interactive
This page shows the latest Akili Interactive news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: Sarepta deepens gene therapy investment, NICE changes mind on Besponsa, Digital Medicine company Akili raises $13m
Digital medicine’ company Akili Interactive raises more funds. Akili Interactive, a company pioneering prescription ‘digital medicine’ for cognitive dysfunction and brain-related conditions, has raised $13 million in new funding. ... Akili says its
Latest news
-
New alliance launches to usher digital therapeutics into the mainstream
The Digital Therapeutics Alliance’s founding members include Voluntis, Propeller Health and Akili Interactive, with the latter’s video game ADHD treatment expected to be submitted for FDA approval in 2018. ... Akili CEO Eddie Martucci said: "Digital
-
Akili to submit video game ADHD treatment for US approval in 2018
Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools. ... Follows trial suggesting attention benefits of its 'digital medicine' AKL-T01. Akili Interactive plans to seek FDA approval for
More from news
Approximately 2 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Ex Sanofi boss joins Boston start-up
Among the 12 companies in PureTech's pipeline are Akili Interactive Labs, which is a collaboration between game designers and neuroscientists to spot signs of the onset of Alzheimer's
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- How COVID-19 is accelerating the threat of antimicrobial resistance
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
- FDA hands BMS and bluebird bio a priority review for ide-cel
- BMS eyes approval for second Opdivo combo in kidney cancer
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Live Webinar: Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients
- Live Webinar: Harnessing Technology to Improve Health and Healthcare
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Lilly’s Verzenio scores a win in early-stage breast cancer
- FDA sets January decision date for Xalkori in ALK-positive lymphoma
- Q&A: Isabel Gibson
PMHub
Purple Agency
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
